Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,418 | 7 | 95.8% |
| Food and Beverage | $396.17 | 28 | 3.3% |
| Education | $102.28 | 5 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $11,627 | 24 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $74.58 | 2 | $0 (2019) |
| PFIZER INC. | $45.45 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $41.00 | 3 | $0 (2020) |
| Travere Therapeutics, Inc. | $36.86 | 3 | $0 (2024) |
| Relypsa, Inc. | $27.79 | 2 | $0 (2019) |
| Vifor Pharma, Inc. | $14.38 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $12.91 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $12.83 | 1 | $0 (2019) |
| Daiichi Sankyo Inc. | $12.68 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62.01 | 4 | Travere Therapeutics, Inc. ($33.78) |
| 2023 | $2,370 | 14 | Bayer Healthcare Pharmaceuticals Inc. ($2,354) |
| 2022 | $9,242 | 10 | Bayer HealthCare Pharmaceuticals Inc. ($9,228) |
| 2021 | $16.58 | 1 | Bayer HealthCare Pharmaceuticals Inc. ($16.58) |
| 2020 | $57.18 | 2 | PFIZER INC. ($45.45) |
| 2019 | $156.00 | 8 | Otsuka America Pharmaceutical, Inc. ($74.58) |
| 2017 | $12.68 | 1 | Daiichi Sankyo Inc. ($12.68) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Cardio-renal | ||||||
| 04/30/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 03/12/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $16.89 | General |
| 12/15/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Cardio-renal | ||||||
| 11/29/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $8.41 | General |
| Category: Cardio-renal | ||||||
| 11/07/2023 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $3.08 | General |
| 09/30/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Cardio-renal | ||||||
| 09/01/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Cardio-renal | ||||||
| 08/04/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.30 | General |
| Category: Cardio-renal | ||||||
| 06/21/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: Cardio-renal | ||||||
| 05/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,230.00 | General |
| Category: Cardio-renal | ||||||
| 04/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Cardio-renal | ||||||
| 04/19/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: Cardio-renal | ||||||
| 03/14/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: KRYSTEXXA | ||||||
| 02/20/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: Cardio-renal | ||||||
| 01/31/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $7.21 | General |
| Category: Cardio-renal | ||||||
| 01/17/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $6.43 | General |
| Category: Cardio-renal | ||||||
| 12/08/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,230.00 | General |
| Category: Cardio-renal | ||||||
| 12/07/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $34.66 | General |
| Category: Cardio-renal | ||||||
| 11/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,230.00 | General |
| Category: Cardio-renal | ||||||
| 11/10/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,805.00 | General |
| Category: Cardio-renal | ||||||
| 08/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $892.00 | General |
| Category: Cardio-renal | ||||||
| 08/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Cardio-renal | ||||||
| 08/02/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 543 | 764 | $154,673 | $62,410 |
| 2022 | 6 | 661 | 926 | $181,090 | $70,783 |
| 2021 | 6 | 599 | 922 | $174,582 | $72,021 |
| 2020 | 6 | 598 | 780 | $113,174 | $41,972 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 301 | 501 | $101,202 | $42,488 | 42.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 135 | 135 | $41,850 | $14,810 | 35.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $4,716 | $1,738 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 25 | $3,425 | $1,658 | 48.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 20 | $2,760 | $1,177 | 42.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 65 | $720.00 | $538.63 | 74.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 362 | 595 | $120,190 | $49,161 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 161 | 161 | $49,910 | $17,275 | 34.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 21 | $5,502 | $2,098 | 38.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 22 | $3,014 | $1,364 | 45.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 11 | 11 | $1,430 | $541.94 | 37.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 91 | 116 | $1,044 | $343.62 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 290 | 581 | $117,362 | $50,158 | 42.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 170 | 170 | $52,700 | $20,112 | 38.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 13 | $1,690 | $707.07 | 41.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $1,507 | $619.02 | 41.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 102 | 134 | $1,206 | $395.75 | 32.8% |
| 81003 | Automated urinalysis test | Office | 2021 | 13 | 13 | $117.00 | $29.25 | 25.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 173 | 295 | $59,590 | $21,420 | 35.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 155 | 155 | $48,050 | $18,223 | 37.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 16 | $1,172 | $840.06 | 71.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 12 | $1,644 | $679.56 | 41.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 123 | 181 | $1,629 | $537.96 | 33.0% |
| 81003 | Automated urinalysis test | Office | 2020 | 121 | 121 | $1,089 | $270.60 | 24.8% |
About Sharan Kanakiriya
Sharan Kanakiriya is a Nephrology healthcare provider based in Kingsport, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558303347.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sharan Kanakiriya has received a total of $11,917 in payments from pharmaceutical and medical device companies, with $62.01 received in 2024. These payments were reported across 40 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,418).
As a Medicare-enrolled provider, Kanakiriya has provided services to 2,401 Medicare beneficiaries, totaling 3,392 services with total Medicare billing of $247,186. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Kingsport, TN
- Active Since 06/13/2006
- Last Updated 01/16/2019
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1558303347
Products in Payments
- Kerendia (Drug) $11,627
- SAMSCA (Drug) $74.58
- PREVNAR 13 (Biological) $45.45
- LOKELMA (Drug) $41.00
- Veltassa (Drug) $27.79
- KRYSTEXXA (Biological) $12.91
- ENTRESTO (Drug) $12.83
- Movantik (Drug) $12.68
- Aimovig (Biological) $11.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Kingsport
Dr. Steven Butler, M.d, M.D
Nephrology — Payments: $1,616
Dr. Sathiyendran Poobalasingham, Md, MD
Nephrology — Payments: $1,576
Dr. Abrar Ahmad, M.d, M.D
Nephrology — Payments: $1,564
Dr. Duc Vu, M.d, M.D
Nephrology — Payments: $429.36